Celecoxib-derivative-pyrazole-sulfonamide-Cpd2
Celecoxib (COX-2 inhibitor and nonsteroidal anti-inflammatory drug (NSAID))derivative containing pyrazole linked-sulfonamide moiety .Ki hCA I 21.70 +/- 2.50 nM; hCA II 4.70 +/- 2.20 nM; AChE 4.58 +/- 0.80 nM
General
Type : Multitarget, Pyrazole, Dimethoxyphenyl, Carbonic anhydrase inhibitor, Sulfur Compound, Cyclooxygenase-2 Inhibitor, Sulfonamide
Chemical_Nomenclature : N-((4-(5-(2,3-dimethoxyphenyl)-4-methyl-1H-pyrazol-1-yl)phenyl)sulfonyl) propionamide
Canonical SMILES : C1=CC(=C(C(=C1)C2=C(C=N[N]2C3=CC=C(C=C3)[S](NC(CC)=O)(=O)=O)C)OC)OC
InChI : InChI=1S\/C21H23N3O5S\/c1-5-19(25)23-30(26,27)16-11-9-15(10-12-16)24-20(14(2)13-22-24)17-7-6-8-18(28-3)21(17)29-4\/h6-13H,5H2,1-4H3,(H,23,25)
InChIKey : OBXCAJROOAQPSV-UHFFFAOYSA-N
Other name(s) : Compound 2
Target
Families : Celecoxib-derivative-pyrazole-sulfonamide-Cpd2 ligand of proteins in family
ACHE
Protein :
human-ACHE
References (1)
| Title : Celecoxib Derivatives Containing Pyrazole Linked-Sulfonamide Moiety: Carbonic Anhydrase III and Acetylcholinesterase Inhibition Profiles, Molecular Docking Studies - Gerni_2023_ChemistrySelect_8_e202302088 |
| Author(s) : Gerni S , Ozturk C , Almaz Z , Bayrak C , Tan A |
| Ref : ChemistrySelect , 8 :e202302088 , 2023 |
| Abstract : |
| PubMedSearch : Gerni_2023_ChemistrySelect_8_e202302088 |
| PubMedID: |